キナーゼに注目

開発新薬の臨床成功！！！

Human Clinical Trial Case1:

• Age:76 Gender: Male

• Diagnosis: Pancreatic head cancer with liver and adrenal metastases.

	96/12/25	97/01/02	97/01/07	97/01/10	97/01/14	97/03/31
AST(GPT)	128	68	-	-	-	67
ALT(GOT)	187	102	-	-	56	78
T-BIL	20.15	16.02	11.71	9.60	7.10	1.43

Summary

The AST and ALT test result of Lee’s diagnosis in December 25^th 2007 was 128 and 187 ng/ml. After using our Anti-cancer peptide drug for few days, the number of AST and ALT were lowered to 68 and 102 ng/ml. Moreover, few days later, the test result of ALT was lowered even more to 56 ng/ml. It is very clear that the number of T-BIL is keeping going down from 20.15 mg/dL to 7.10 mg/dL in less than one month. According to his daughter, Lee has already gained his weight, and he looks healthier. Recently, he can even do some gardening at his own back yard.